The aim of this experimental study was to examine the effect of erythropoietin (EPO) on rat model and particularly in an ischemia-reperfusion (IR) protocol. The effect of that molecule was studied biochemically using blood mean amylase levels.
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patients' health. Although important progress has been made regarding the usage of erythropoietin (Epo) in managing this kind of damages, satisfactory answers have not been given yet to fundamental questions, as, by what velocity this factor acts, when should it be administered, and in which dosage. The particularly satisfactory action of Epo in stem blood cells recovery has been noted in several performed experiments. However, just few relative reports were found concerning Epo trial in IR experiments, not covering completely this particular matter. A meta-analysis of 13 published seric variables, coming from the same experimental setting, tried to provide a numeric evaluation of the Epo efficacy at the same endpoints (Table 1) . Furthermore, several publications addressed trials of other similar molecules of growth factors to which the studied molecule also belongs to.
The aim of this experimental study was to examine the effect of Epo on rat model and particularly in a pancreas IR protocol. The effect of that molecule was studied by measuring the blood mean amylase (A) levels.
MATERIALS And METhodS

Animal Preparation
This experimental study was licensed by Veterinary Address of East Attiki prefecture under 3693/12-11-2010 and 14/10-1-2012 decisions. All settings needed for the study including consumables, equipment and substances used, were a courtesy of Experimental Research Center of Elpen pharmaceuticals Co. Inc. SA at pikerni, Attiki. Accepted standards of humane animal care were adopted for Albino female Wistar rats. Normal housing in laboratory 7 days before the experiment included continuous access to water and food. The experiment was acute, that means that awakening and preservation of the rodents was not following the experiment. They were randomly delivered to four experimental groups by 10 animals in each one. Ischemia for 45 minutes followed by reperfusion for 60 minutes (group A). Ischemia for 45 minutes followed by reperfusion for 120 minutes (group B). Ischemia for 45 minutes followed by immediate Epo intravenous (IV) administration and reperfusion for 60 minutes (group C). Ischemia for 45 minutes followed by immediate Epo IV administration and reperfusion for jpmer 120 minutes (group D). The molecule Epo dosage was 10 mg/kg body weight of animals.
At first, the animals were submitted into prenarcosis followed by general anesthesia. The detailed anesthesiologic technique is described in related references. 1, 2 oxygen supply, electrocardiogram and acidimetry were continuously provided during whole experiment performance.
The protocol of IR was followed. Ischemia was caused by forceps clamping inferior aorta over renal arteries for 45 minutes after laparotomic access had been achieved. Reperfusion was induced by removing the clamp and re-establishment of inferior aorta patency. The molecules were administered at the time of reperfusion, through inferior vena cava after catheterization had been achieved. The amylase levels measurements were performed at 60 minutes of reperfusion (groups A and C) and at 120 minutes of reperfusion (groups B and D). The mean weight of the 40 female Wistar albino rats used was 231.875 gm (SD: 36.59703 gm), with minimum weight ≥ 165 gm and maximum weight ≤ 320 gm. Rats' weight could be potentially a confusing factor, e.g. fatter rats to have greater blood amylase levels. This suspicion was investigated.
ModEL of ISChEMIA-REPERfuSIon InjuRy
Control Group
Twenty control rats of mean weight 252.5 gm (SD: 39.31988 gm) suffered by ischemia for 45 minutes followed by reperfusion.
Group A: Reperfusion which lasted 60 minutes concerned 10 control rats of mean weight 243 gm (SD: 45.77724 gm) and mean A levels 1674 IU/l (SD: 282.0162 IU/l) ( Table 2 ).
Group B:
Reperfusion which lasted 120 minutes concerned 10 control rats of mean weight 262 gm (SD: 31.10913 gm) and mean A levels 1877 IU/l (SD: 354.5749 IU/l) ( Table 2) .
Erythropoietin Group
Twenty Epo rats of mean weight 242.9 gm (SD: 30.3105 gm) suffered by ischemia for 45 minutes followed by reperfusion in the beginning of which 10 mg Epo/kg body weight were IV administered.
Group C: Reperfusion which lasted 60 minutes concerned 10 Epo rats of mean weight 242.8 gm (SD: 29.33636 gm) and mean A levels 1786.5 IU/l (SD: 372.3598 IU/l) ( Table 2 ).
Group D:
Reperfusion which lasted 120 minutes concerned 10 Epo rats of mean weight 243 gm (SD: 32.84644 gm) and mean A levels 1945.8 IU/l (SD: 315.7716 IU/l) ( Table 2) .
RESuLTS
Initially, every one from 4 rats weight groups was compared with each other from 3 remained groups applying statistical paired t-test (Table 3) . Any emerging significant difference among A levels, was investigated whether owed in the above mentioned significant weight correlations. Also, every one from 4 rats A levels groups was compared with each other from 3 remained groups app lying statistical paired t-test. (Table 3 ). Applying generalized linear models (glm) with dependant variable the A levels observed no significant change in amylase level after hrEpo administration in weekly increasing doses.
ConCLuSIon
Erythropoietin administration, reperfusion time and their interaction kept non-significantly short-term increased the amylase levels. The restorating effect of Epo is satisfactory since it reduced the discrepancy from baseline values at non-significant level. perhaps, a longer study time than 2 hours or a greater Epo dose might reveal full restoration.
